lt p gt International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells hpSCs and the development and commercialization of cell based research and cosmetic products. ISCO s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes eggs . hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial backgrounds, with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell . ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology www.lifelinecelltech.com , and stem cell based skin care products through its subsidiary Lifeline Skin Care www.lifelineskincare.com . lt /p gt
Quote | International Stem Cell Corp (OTCMKTS:ISCO)
Last: | $0.065 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0612 |
Close: | $0.065 |
High: | $0.06837 |
Low: | $0.0612 |
Volume: | 1,566 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | International Stem Cell Corp (OTCMKTS:ISCO)
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...
Message Board Posts | International Stem Cell Corp (OTCMKTS:ISCO)
Subject | By | Source | When |
---|---|---|---|
We've been popping the last couple trading days. | BearGator56 | investorshub | 08/08/2022 2:06:14 PM |
I am mostly curious as to when they | drkazmd65 | investorshub | 05/17/2022 2:19:31 PM |
NEWS -- International Stem Cell Corporation Announces Strong | Paulness | investorshub | 05/17/2022 11:56:46 AM |
Nice to see the Improved Financials out today!!! | Doctor_Hari_Seldon | investorshub | 05/17/2022 11:05:15 AM |
It has always amazed me how much under | Doctor_Hari_Seldon | investorshub | 07/01/2021 11:29:02 PM |
News, Short Squeeze, Breakout and More Instantly...
International Stem Cell Corp Company Name:
ISCO Stock Symbol:
OTCMKTS Market:
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...
Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...